CHARLOTTESVILLE, VA (January 26, 2010) – Lodewijk J.R. de Vink, an internationally-known leader in the pharmaceutical and healthcare industries, was elected to the Board of Directors of the Focused Ultrasound Surgery Foundation at its January 26 meeting. He will serve a term of three years.
A founding partner of Blackstone Health Care Partners since April 2003, de Vink’s earlier executive positions included Chairman, International Health Care Partners; Chairman, President and Chief Executive Officer of Warner-Lambert Company; and President of Schering International.
In addition to the Foundation board, de Vink is a member of the Board of Directors of Alcon, Inc.; Flamel Technologies S.A.; and Roche Holdings A.G. He is also on Sotheby’s International Advisory Board, and the European Advisory Council of Rothschild & Cie.
A Netherlands native, de Vink graduated from Nijenrode, the Netherlands School of Business. He later earned a B.B.A. from Washburn University in Topeka, Kansas, and an M.B.A. from American University in Washington, D.C.
“We welcome Lodewijk to the Board and deeply value his experience and expertise,” says Neal F. Kassell, M.D., the Foundation’s Chairman. “His extensive knowledge of the pharmaceutical industry and his stature in the international healthcare market will be crucial in our efforts to establish focused ultrasound as a platform for drug delivery.”
Other members of the Foundation’s Board of Directors are: Dorothy Batten; S. Morry Blumenfeld, Ph.D., Founding Partner of Meditech Advisors Management; Eugene V. Fife, Chairman of Eclipsys Corporation; best-selling author John Grisham; David Heller, Chairman of Advisory Research Inc.; Dan Jordan, former President of the Thomas Jefferson Foundation; Neal F. Kassell, M.D., Professor of Neurosurgery at the University of Virginia; Steve Rusckowski, Executive Vice-President and Chief Executive Officer of Philips Healthcare; and, Kobi Vortman, Ph.D., Chief Executive Officer of InSightec.
About the Focused Ultrasound Surgery Foundation